COMMUNIQUÉS West-GlobeNewswire

Data from Celtaxsys’ Acebilustat Phase 2 Trial addressing Lung Inflammation in CF Patients to be presented at the North American Cystic Fibrosis Conference

11/10/2018 - 14:00

ATLANTA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Full results from the recently completed Phase 2 trial (EMPIRE-CF) of Celtaxsys’ acebilustat will be presented at the North American Cystic Fibrosis Conference to be held [...]

Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification

11/10/2018 - 14:00

DANVERS, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, November 1, 2018, the Company will release financial results for the second quarter of fiscal 2019. The Company [...]

iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis

11/10/2018 - 14:00

Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography Company to showcase latest [...]

Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR206

11/10/2018 - 14:00

CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]

Sirona Biochem to Present at the 2018 Arctic Circle Assembly

11/10/2018 - 14:00

VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (the “ Company ”) announced today that Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy will [...]

Dermavant Sciences to Present Tapinarof Phase 2b Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference

11/10/2018 - 14:00

BASEL, Switzerland, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that two abstracts containing Phase 2b data on patient-reported outcomes in [...]

Biogen Advances Research to Improve Outcomes for Patients With Multiple Sclerosis

11/10/2018 - 13:30

Evidence supports potential of serum neurofilament light (sNfL) as clinically useful biomarker in MS; Biogen and Siemens Healthineers collaborate to develop sNfL blood test Real-world data add to the large body of [...]

ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson’s Disease

11/10/2018 - 13:30

Unique discovery platform generates new antibody candidates that block a root cause of Parkinson’s Disease TORONTO and CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: [...]

Pain Therapeutics Announces Appointment of Chief Financial Officer

11/10/2018 - 13:30

AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that Mr. Eric Schoen will join its management team as Chief Financial Officer, [...]

Integrated Cannabis Company, Inc. Announces Fall 2018 Collaboration to Launch CBD Products in the Colorado Market

11/10/2018 - 13:30

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, [...]

Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares

11/10/2018 - 13:30

MONTRÉAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]

Resonant Inc. Appoints Tech and Finance Executive Bob Tirva to its Board of Directors

11/10/2018 - 13:05

- Respected tech industry veteran brings more than 25 years of comprehensive financial expertise - GOLETA, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio [...]

Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis

11/10/2018 - 13:00

TEL AVIV, Israel, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), announced today that a study entitled “MOSPD2: A Novel Therapeutic Target for the Treatment of CNS Inflammation,” is being presented [...]

Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract for ESMO 2018 Congress

11/10/2018 - 13:00

- Pelareorep and FOLFIRI/B combination shows superior OS & PFS data in KRAS mutant colorectal cancer compared to historical data - CALGARY, Alberta and SAN DIEGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech [...]

Ogilvy CommonHealth Worldwide’s Johanna Skilling honored as a 2018 Agency Vanguard Award Winner

11/10/2018 - 13:00

PARSIPPANY, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP, www.wpp.com ), today announced Johanna Skilling, head of [...]

Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute Pain

11/10/2018 - 13:00

Anesthetic and Analgesic Drug Products Advisory Committee Meeting October 11, 2018 CHESTERBROOK, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced that NASDAQ has halted trading of the [...]

Axsome Therapeutics to Focus on Growing Core CNS Portfolio; Establishes Axsome Pain and Primary Care Business Unit to Enhance Value of Non-CNS Assets

11/10/2018 - 13:00

Axsome PPC to include three novel, non-opioid, Phase 3-stage product candidates for chronic pain 145 issued Axsome PPC patents, including 21 covering neridronate, provide protection as far as 2036 Indications include [...]

Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President

11/10/2018 - 13:00

TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF ) ("Emblem" or the "Company") today announced additional leadership and operational resources to support the rapid growth of its medical [...]

Emerald Health Therapeutics Promotes Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing

11/10/2018 - 13:00

VICTORIA, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced the promotion of Paul R. Dillman, Jr. to Executive Vice President of [...]